Circio Holding ASA
The answer first
Does Circio Holding beat the market?
Yes, Circio Holding has beaten the market over the last year.
The ranking · Quality, value and trend combined
Better than 28% of Nordic stocks
- Quality38
- Value6
- Trend77
No. 109 of 195 in healthcare
Max for seven days
Follow Circio Holding with AuroraAurora lets you know at the next report. No card.
Both with dividends. Figures as of 19 November 2026. General analysis, not personal advice.
Follow your thesis
Ask Aurora about Circio Holding
Your first answer is free, no account needed.
Do you own Circio Holding, or are you thinking about it?
See it next to the rest of your portfolio, or build your first one with Circio Holding and a few more. Free, no card.
Super Stock+44.6%In short
- Circio Holding has risen 458.4% over the past year, including dividends.
- Overall, Circio Holding ranks better than 28% of Nordic stocks on quality, value and trend.
- The largest fall over the past three years was 99.6%. The price is 98.7% below its peak now.
Quality, value and trend
Quality is about the company, value about the price you pay, and trend about the share price. Each pillar shows the numbers it is built on.
Quality, value and trend together. Better than 28% of Nordic stocks.
No. 109 of 195 in healthcare
Medium An average company: the accounts are neither especially strong nor weak.
No. 149 of 196 in healthcareTypical in healthcare: 64Typical in the Nordics: 50
- Debt to equityBorrowings divided by equity0.00
- Asset turnoverSales divided by everything the company owns0.00
- Return on equityProfit divided by equity−1.8%
- Cash conversionOperating cash flow divided by profit–
The ranking is built on equity ratio, ROA and how steadily profit grows.
Low High price: buyers pay a lot today, often because they expect growth.
No. 156 of 197 in healthcareTypical in healthcare: 20Typical in the Nordics: 50
- P/BPrice divided by equity4.9
- P/SPrice divided by sales212.2
- P/EPrice divided by earningsnegative earnings
- P/CFPrice divided by operating cash flownegative earnings
The ranking is built on P/E, P/B and P/S.
High Tailwind in the share price: it has risen more than most over the last year.
No. 45 of 198 in healthcareTypical in healthcare: 34Typical in the Nordics: 50
- 3 months−1.0%
- 6 months−2.8%
- 9 months+518.7%
- 12 months+458.4%
The ranking is built on 3, 6 and 12–1 months.
Return and risk
Return with dividends reinvested.
The funds that own Circio Holding
2 funds we follow own Circio Holding. The share is how much of the fund the stock makes up.
- Norway1
- Sweden1
From the funds' latest known holdings.
About Circio Holding
Circio Holding ASA is a company in healthcare, listed on Oslo Børs. The share trades in NOK. It has around 10 employees.
Circio Holding ASA, a biotechnology company, develops novel circular RNA expression technology for gene and cell therapy. The company is developing TG01, a cancer vaccine targeting driver mutations, which is in three clinical trials for multiple myeloma, and pancreatic and lung cancer; and circVec circRNA vector platform, a modular genetic cassette for biogenesis of multifunctional circRNAs in human cells. It has a research collaboration with United Immunity Co., Ltd. for the development of vivo CAR-Macrophage (CAR-M) therapy; and Suzhou GenAssist Therapeutics Co., Ltd. to develop circVec-enhanced AAV vectors engineered for in vivo cell therapy and low dose systemic gene therapy.


See the full analysis of Circio Holding.
The accounts, dividends, 40 years of charts and the comparison with other stocks are in the app.
Free forever · No card